Screening out irrelevant cell-based models of disease.
Identifieur interne : 003B24 ( Ncbi/Merge ); précédent : 003B23; suivant : 003B25Screening out irrelevant cell-based models of disease.
Auteurs : Peter Horvath [Finlande] ; Nathalie Aulner [France] ; Marc Bickle [Allemagne] ; Anthony M. Davies ; Elaine Del Nery [France] ; Daniel Ebner [Royaume-Uni] ; Maria C. Montoya [Espagne] ; P Ivi Östling [Finlande] ; Vilja Pieti Inen [Finlande] ; Leo S. Price [Pays-Bas] ; Spencer L. Shorte [France] ; Gerardo Turcatti [Suisse] ; Carina Von Schantz [Finlande] ; Neil O. Carragher [Royaume-Uni]Source :
- Nature reviews. Drug discovery [ 1474-1784 ] ; 2016.
Descripteurs français
- KwdFr :
- Animaux, Cellules souches pluripotentes induites (), Cellules souches pluripotentes induites (physiologie), Découverte de médicament (), Humains, Lignée de cellules transformées, Modèles biologiques, Préparations pharmaceutiques (administration et posologie), Techniques de culture cellulaire (), Tests de criblage à haut débit (), Évaluation préclinique de médicament ().
- MESH :
- administration et posologie : Préparations pharmaceutiques.
- physiologie : Cellules souches pluripotentes induites.
- Animaux, Cellules souches pluripotentes induites, Découverte de médicament, Humains, Lignée de cellules transformées, Modèles biologiques, Techniques de culture cellulaire, Tests de criblage à haut débit, Évaluation préclinique de médicament.
English descriptors
- KwdEn :
- Animals, Cell Culture Techniques (methods), Cell Line, Transformed, Drug Discovery (methods), Drug Evaluation, Preclinical (methods), High-Throughput Screening Assays (methods), Humans, Induced Pluripotent Stem Cells (drug effects), Induced Pluripotent Stem Cells (physiology), Models, Biological, Pharmaceutical Preparations (administration & dosage).
- MESH :
- chemical , administration & dosage : Pharmaceutical Preparations.
- drug effects : Induced Pluripotent Stem Cells.
- methods : Cell Culture Techniques, Drug Discovery, Drug Evaluation, Preclinical, High-Throughput Screening Assays.
- physiology : Induced Pluripotent Stem Cells.
- Animals, Cell Line, Transformed, Humans, Models, Biological.
Abstract
The common and persistent failures to translate promising preclinical drug candidates into clinical success highlight the limited effectiveness of disease models currently used in drug discovery. An apparent reluctance to explore and adopt alternative cell- and tissue-based model systems, coupled with a detachment from clinical practice during assay validation, contributes to ineffective translational research. To help address these issues and stimulate debate, here we propose a set of principles to facilitate the definition and development of disease-relevant assays, and we discuss new opportunities for exploiting the latest advances in cell-based assay technologies in drug discovery, including induced pluripotent stem cells, three-dimensional (3D) co-culture and organ-on-a-chip systems, complemented by advances in single-cell imaging and gene editing technologies. Funding to support precompetitive, multidisciplinary collaborations to develop novel preclinical models and cell-based screening technologies could have a key role in improving their clinical relevance, and ultimately increase clinical success rates.
DOI: 10.1038/nrd.2016.175
PubMed: 27616293
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001655
- to stream PubMed, to step Curation: 001633
- to stream PubMed, to step Checkpoint: 001633
Links to Exploration step
pubmed:27616293Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Screening out irrelevant cell-based models of disease.</title><author><name sortKey="Horvath, Peter" sort="Horvath, Peter" uniqKey="Horvath P" first="Peter" last="Horvath">Peter Horvath</name><affiliation wicri:level="4"><nlm:affiliation>Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged H-6726, Hungary; and at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged H-6726, Hungary; and at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Aulner, Nathalie" sort="Aulner, Nathalie" uniqKey="Aulner N" first="Nathalie" last="Aulner">Nathalie Aulner</name><affiliation wicri:level="1"><nlm:affiliation>Imagopole-Citech, Institut Pasteur, Paris 75015, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Imagopole-Citech, Institut Pasteur, Paris 75015</wicri:regionArea><wicri:noRegion>75015</wicri:noRegion><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Bickle, Marc" sort="Bickle, Marc" uniqKey="Bickle M" first="Marc" last="Bickle">Marc Bickle</name><affiliation wicri:level="3"><nlm:affiliation>Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden 01307, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden 01307</wicri:regionArea><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Dresde</region><settlement type="city">Dresde</settlement></placeName></affiliation></author><author><name sortKey="Davies, Anthony M" sort="Davies, Anthony M" uniqKey="Davies A" first="Anthony M" last="Davies">Anthony M. Davies</name><affiliation><nlm:affiliation>Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology, Brisbane 4102 QLD, Australia; and The Irish National Centre for High Content Screening and Analysis, Trinity Translational Medicine Institute, Trinity College Dublin, Phase 3 Trinity Health Sciences 1.20, St James Hospital, Dublin D8, Republic of Ireland.</nlm:affiliation><wicri:noCountry code="subField">Republic of Ireland</wicri:noCountry></affiliation></author><author><name sortKey="Nery, Elaine Del" sort="Nery, Elaine Del" uniqKey="Nery E" first="Elaine Del" last="Nery">Elaine Del Nery</name><affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, Department of Translational Research, The Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), F-75005, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Curie, PSL Research University, Department of Translational Research, The Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), F-75005, Paris</wicri:regionArea><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Ebner, Daniel" sort="Ebner, Daniel" uniqKey="Ebner D" first="Daniel" last="Ebner">Daniel Ebner</name><affiliation wicri:level="4"><nlm:affiliation>Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Target Discovery Institute, University of Oxford, Oxford OX3 7FZ</wicri:regionArea><orgName type="university">Université d'Oxford</orgName><placeName><settlement type="city">Oxford</settlement><region type="nation">Angleterre</region><region type="région" nuts="1">Oxfordshire</region></placeName></affiliation></author><author><name sortKey="Montoya, Maria C" sort="Montoya, Maria C" uniqKey="Montoya M" first="Maria C" last="Montoya">Maria C. Montoya</name><affiliation wicri:level="1"><nlm:affiliation>Cellomics Unit, Cell Biology &Physiology Program, Cell &Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Cellomics Unit, Cell Biology &Physiology Program, Cell &Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Ostling, P Ivi" sort="Ostling, P Ivi" uniqKey="Ostling P" first="P Ivi" last="Östling">P Ivi Östling</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Pieti Inen, Vilja" sort="Pieti Inen, Vilja" uniqKey="Pieti Inen V" first="Vilja" last="Pieti Inen">Vilja Pieti Inen</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Price, Leo S" sort="Price, Leo S" uniqKey="Price L" first="Leo S" last="Price">Leo S. Price</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Science, Leiden Academic Centre for Drug Research, Toxicology, Universiteit Leiden, The Netherlands; and at OcellO, J.H Oortweg 21, 2333 CH, Leiden, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Faculty of Science, Leiden Academic Centre for Drug Research, Toxicology, Universiteit Leiden, The Netherlands; and at OcellO, J.H Oortweg 21, 2333 CH, Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Shorte, Spencer L" sort="Shorte, Spencer L" uniqKey="Shorte S" first="Spencer L" last="Shorte">Spencer L. Shorte</name><affiliation wicri:level="3"><nlm:affiliation>Imagopole-Citech, Institut Pasteur, Paris 75015, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Imagopole-Citech, Institut Pasteur, Paris 75015</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Turcatti, Gerardo" sort="Turcatti, Gerardo" uniqKey="Turcatti G" first="Gerardo" last="Turcatti">Gerardo Turcatti</name><affiliation wicri:level="1"><nlm:affiliation>Biomolecular Screening Facility, Swiss Federal Institute of Technology (EPFL), Lausanne CH-1015, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Biomolecular Screening Facility, Swiss Federal Institute of Technology (EPFL), Lausanne CH-1015</wicri:regionArea><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation></author><author><name sortKey="Von Schantz, Carina" sort="Von Schantz, Carina" uniqKey="Von Schantz C" first="Carina" last="Von Schantz">Carina Von Schantz</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Carragher, Neil O" sort="Carragher, Neil O" uniqKey="Carragher N" first="Neil O" last="Carragher">Neil O. Carragher</name><affiliation wicri:level="4"><nlm:affiliation>Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR</wicri:regionArea><orgName type="university">Université d'Édimbourg</orgName><placeName><settlement type="city">Édimbourg</settlement><region type="country">Écosse</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27616293</idno><idno type="pmid">27616293</idno><idno type="doi">10.1038/nrd.2016.175</idno><idno type="wicri:Area/PubMed/Corpus">001655</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001655</idno><idno type="wicri:Area/PubMed/Curation">001633</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001633</idno><idno type="wicri:Area/PubMed/Checkpoint">001633</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001633</idno><idno type="wicri:Area/Ncbi/Merge">003B24</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Screening out irrelevant cell-based models of disease.</title><author><name sortKey="Horvath, Peter" sort="Horvath, Peter" uniqKey="Horvath P" first="Peter" last="Horvath">Peter Horvath</name><affiliation wicri:level="4"><nlm:affiliation>Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged H-6726, Hungary; and at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged H-6726, Hungary; and at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Aulner, Nathalie" sort="Aulner, Nathalie" uniqKey="Aulner N" first="Nathalie" last="Aulner">Nathalie Aulner</name><affiliation wicri:level="1"><nlm:affiliation>Imagopole-Citech, Institut Pasteur, Paris 75015, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Imagopole-Citech, Institut Pasteur, Paris 75015</wicri:regionArea><wicri:noRegion>75015</wicri:noRegion><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Bickle, Marc" sort="Bickle, Marc" uniqKey="Bickle M" first="Marc" last="Bickle">Marc Bickle</name><affiliation wicri:level="3"><nlm:affiliation>Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden 01307, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden 01307</wicri:regionArea><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Dresde</region><settlement type="city">Dresde</settlement></placeName></affiliation></author><author><name sortKey="Davies, Anthony M" sort="Davies, Anthony M" uniqKey="Davies A" first="Anthony M" last="Davies">Anthony M. Davies</name><affiliation><nlm:affiliation>Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology, Brisbane 4102 QLD, Australia; and The Irish National Centre for High Content Screening and Analysis, Trinity Translational Medicine Institute, Trinity College Dublin, Phase 3 Trinity Health Sciences 1.20, St James Hospital, Dublin D8, Republic of Ireland.</nlm:affiliation><wicri:noCountry code="subField">Republic of Ireland</wicri:noCountry></affiliation></author><author><name sortKey="Nery, Elaine Del" sort="Nery, Elaine Del" uniqKey="Nery E" first="Elaine Del" last="Nery">Elaine Del Nery</name><affiliation wicri:level="3"><nlm:affiliation>Institut Curie, PSL Research University, Department of Translational Research, The Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), F-75005, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut Curie, PSL Research University, Department of Translational Research, The Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), F-75005, Paris</wicri:regionArea><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Ebner, Daniel" sort="Ebner, Daniel" uniqKey="Ebner D" first="Daniel" last="Ebner">Daniel Ebner</name><affiliation wicri:level="4"><nlm:affiliation>Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Target Discovery Institute, University of Oxford, Oxford OX3 7FZ</wicri:regionArea><orgName type="university">Université d'Oxford</orgName><placeName><settlement type="city">Oxford</settlement><region type="nation">Angleterre</region><region type="région" nuts="1">Oxfordshire</region></placeName></affiliation></author><author><name sortKey="Montoya, Maria C" sort="Montoya, Maria C" uniqKey="Montoya M" first="Maria C" last="Montoya">Maria C. Montoya</name><affiliation wicri:level="1"><nlm:affiliation>Cellomics Unit, Cell Biology &Physiology Program, Cell &Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Cellomics Unit, Cell Biology &Physiology Program, Cell &Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Ostling, P Ivi" sort="Ostling, P Ivi" uniqKey="Ostling P" first="P Ivi" last="Östling">P Ivi Östling</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Pieti Inen, Vilja" sort="Pieti Inen, Vilja" uniqKey="Pieti Inen V" first="Vilja" last="Pieti Inen">Vilja Pieti Inen</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Price, Leo S" sort="Price, Leo S" uniqKey="Price L" first="Leo S" last="Price">Leo S. Price</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Science, Leiden Academic Centre for Drug Research, Toxicology, Universiteit Leiden, The Netherlands; and at OcellO, J.H Oortweg 21, 2333 CH, Leiden, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Faculty of Science, Leiden Academic Centre for Drug Research, Toxicology, Universiteit Leiden, The Netherlands; and at OcellO, J.H Oortweg 21, 2333 CH, Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Shorte, Spencer L" sort="Shorte, Spencer L" uniqKey="Shorte S" first="Spencer L" last="Shorte">Spencer L. Shorte</name><affiliation wicri:level="3"><nlm:affiliation>Imagopole-Citech, Institut Pasteur, Paris 75015, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Imagopole-Citech, Institut Pasteur, Paris 75015</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region></placeName></affiliation></author><author><name sortKey="Turcatti, Gerardo" sort="Turcatti, Gerardo" uniqKey="Turcatti G" first="Gerardo" last="Turcatti">Gerardo Turcatti</name><affiliation wicri:level="1"><nlm:affiliation>Biomolecular Screening Facility, Swiss Federal Institute of Technology (EPFL), Lausanne CH-1015, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Biomolecular Screening Facility, Swiss Federal Institute of Technology (EPFL), Lausanne CH-1015</wicri:regionArea><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation></author><author><name sortKey="Von Schantz, Carina" sort="Von Schantz, Carina" uniqKey="Von Schantz C" first="Carina" last="Von Schantz">Carina Von Schantz</name><affiliation wicri:level="4"><nlm:affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290</wicri:regionArea><orgName type="university">Université d'Helsinki</orgName><placeName><settlement type="city">Helsinki</settlement><region type="région" nuts="2">Uusimaa</region></placeName></affiliation></author><author><name sortKey="Carragher, Neil O" sort="Carragher, Neil O" uniqKey="Carragher N" first="Neil O" last="Carragher">Neil O. Carragher</name><affiliation wicri:level="4"><nlm:affiliation>Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR</wicri:regionArea><orgName type="university">Université d'Édimbourg</orgName><placeName><settlement type="city">Édimbourg</settlement><region type="country">Écosse</region></placeName></affiliation></author></analytic><series><title level="j">Nature reviews. Drug discovery</title><idno type="eISSN">1474-1784</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Cell Culture Techniques (methods)</term><term>Cell Line, Transformed</term><term>Drug Discovery (methods)</term><term>Drug Evaluation, Preclinical (methods)</term><term>High-Throughput Screening Assays (methods)</term><term>Humans</term><term>Induced Pluripotent Stem Cells (drug effects)</term><term>Induced Pluripotent Stem Cells (physiology)</term><term>Models, Biological</term><term>Pharmaceutical Preparations (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Cellules souches pluripotentes induites ()</term><term>Cellules souches pluripotentes induites (physiologie)</term><term>Découverte de médicament ()</term><term>Humains</term><term>Lignée de cellules transformées</term><term>Modèles biologiques</term><term>Préparations pharmaceutiques (administration et posologie)</term><term>Techniques de culture cellulaire ()</term><term>Tests de criblage à haut débit ()</term><term>Évaluation préclinique de médicament ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Pharmaceutical Preparations</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Préparations pharmaceutiques</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Induced Pluripotent Stem Cells</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Cell Culture Techniques</term><term>Drug Discovery</term><term>Drug Evaluation, Preclinical</term><term>High-Throughput Screening Assays</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Cellules souches pluripotentes induites</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Induced Pluripotent Stem Cells</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cell Line, Transformed</term><term>Humans</term><term>Models, Biological</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Cellules souches pluripotentes induites</term><term>Découverte de médicament</term><term>Humains</term><term>Lignée de cellules transformées</term><term>Modèles biologiques</term><term>Techniques de culture cellulaire</term><term>Tests de criblage à haut débit</term><term>Évaluation préclinique de médicament</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The common and persistent failures to translate promising preclinical drug candidates into clinical success highlight the limited effectiveness of disease models currently used in drug discovery. An apparent reluctance to explore and adopt alternative cell- and tissue-based model systems, coupled with a detachment from clinical practice during assay validation, contributes to ineffective translational research. To help address these issues and stimulate debate, here we propose a set of principles to facilitate the definition and development of disease-relevant assays, and we discuss new opportunities for exploiting the latest advances in cell-based assay technologies in drug discovery, including induced pluripotent stem cells, three-dimensional (3D) co-culture and organ-on-a-chip systems, complemented by advances in single-cell imaging and gene editing technologies. Funding to support precompetitive, multidisciplinary collaborations to develop novel preclinical models and cell-based screening technologies could have a key role in improving their clinical relevance, and ultimately increase clinical success rates.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27616293</PMID><DateCreated><Year>2016</Year><Month>09</Month><Day>12</Day></DateCreated><DateCompleted><Year>2017</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-1784</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>11</Month></PubDate></JournalIssue><Title>Nature reviews. Drug discovery</Title><ISOAbbreviation>Nat Rev Drug Discov</ISOAbbreviation></Journal><ArticleTitle>Screening out irrelevant cell-based models of disease.</ArticleTitle><Pagination><MedlinePgn>751-769</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nrd.2016.175</ELocationID><Abstract><AbstractText>The common and persistent failures to translate promising preclinical drug candidates into clinical success highlight the limited effectiveness of disease models currently used in drug discovery. An apparent reluctance to explore and adopt alternative cell- and tissue-based model systems, coupled with a detachment from clinical practice during assay validation, contributes to ineffective translational research. To help address these issues and stimulate debate, here we propose a set of principles to facilitate the definition and development of disease-relevant assays, and we discuss new opportunities for exploiting the latest advances in cell-based assay technologies in drug discovery, including induced pluripotent stem cells, three-dimensional (3D) co-culture and organ-on-a-chip systems, complemented by advances in single-cell imaging and gene editing technologies. Funding to support precompetitive, multidisciplinary collaborations to develop novel preclinical models and cell-based screening technologies could have a key role in improving their clinical relevance, and ultimately increase clinical success rates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horvath</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Synthetic and Systems Biology Unit, Biological Research Centre of the Hungarian Academy of Sciences, Szeged H-6726, Hungary; and at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aulner</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Imagopole-Citech, Institut Pasteur, Paris 75015, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bickle</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden 01307, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Anthony M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology, Brisbane 4102 QLD, Australia; and The Irish National Centre for High Content Screening and Analysis, Trinity Translational Medicine Institute, Trinity College Dublin, Phase 3 Trinity Health Sciences 1.20, St James Hospital, Dublin D8, Republic of Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nery</LastName><ForeName>Elaine Del</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Institut Curie, PSL Research University, Department of Translational Research, The Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), F-75005, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebner</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montoya</LastName><ForeName>Maria C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Cellomics Unit, Cell Biology &Physiology Program, Cell &Developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Östling</LastName><ForeName>Päivi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Science for Life Laboratory, Department of Oncology and Pathology, Karolinska Institutet, Stockholm 17165, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietiäinen</LastName><ForeName>Vilja</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Leo S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Faculty of Science, Leiden Academic Centre for Drug Research, Toxicology, Universiteit Leiden, The Netherlands; and at OcellO, J.H Oortweg 21, 2333 CH, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorte</LastName><ForeName>Spencer L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Imagopole-Citech, Institut Pasteur, Paris 75015, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turcatti</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biomolecular Screening Facility, Swiss Federal Institute of Technology (EPFL), Lausanne CH-1015, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Schantz</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00290, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carragher</LastName><ForeName>Neil O</ForeName><Initials>NO</Initials><AffiliationInfo><Affiliation>Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Cell-Based Assays Interest Group.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Drug Discov</MedlineTA><NlmUniqueID>101124171</NlmUniqueID><ISSNLinking>1474-1776</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Science. 2005 Nov 18;310(5751):1139-43</RefSource><PMID Version="1">16293750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Stem Cells. 2015;10(1):43-62</RefSource><PMID Version="1">26665937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(10 ):e26397</RefSource><PMID Version="1">22028871</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cells Transl Med. 2014 Feb;3(2):141-8</RefSource><PMID Version="1">24375539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2010 Jul 1;148(1):16-23</RefSource><PMID Version="1">20083148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2016;1307:173-90</RefSource><PMID Version="1">24615461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Toxicol Methods. 2012 Nov-Dec;66(3):246-56</RefSource><PMID Version="1">22926323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2004 Jul 8;430(6996):242-9</RefSource><PMID Version="1">15241422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2014 Jul 14;20(26):8491-504</RefSource><PMID Version="1">25024605</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2015 Apr;14(4):248-60</RefSource><PMID Version="1">25792263</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Toxicol Methods. 2012 May-Jun;65(3):126-35</RefSource><PMID Version="1">22521339</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Discov Today. 2015 Apr;20(4):450-7</RefSource><PMID Version="1">25572406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Genet. 2015 May;16(5):299-311</RefSource><PMID Version="1">25854182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 2015 May;95(5):515-24</RefSource><PMID Version="1">25686096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Toxicol. 2015 Apr;15(2):127-39</RefSource><PMID Version="1">25134468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Drugs. 2005 Jul;16(6):609-15</RefSource><PMID Version="1">15930887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ACS Synth Biol. 2016 Oct 21;5(10 ):1040-1049</RefSource><PMID Version="1">27076218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Toxicol. 2006 Sep;80(9):580-604</RefSource><PMID Version="1">16598496</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2010 Jul 9;107(1):35-44</RefSource><PMID Version="1">20448218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2014 Jan;42(Database issue):D1040-7</RefSource><PMID Version="1">24304894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Pharmacol Toxicol. 2012;52:505-21</RefSource><PMID Version="1">22235860</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2016 Feb;12(2):109-16</RefSource><PMID Version="1">26656090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2014 Sep 10;6(253):253ps10</RefSource><PMID Version="1">25210060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jan 28;6:20011</RefSource><PMID Version="1">26817415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Jun 18;522(7556):315-20</RefSource><PMID Version="1">26085270</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 2016 Mar;1863(3):414-26</RefSource><PMID Version="1">26255027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Feb 3;470(7332):105-9</RefSource><PMID Version="1">21151107</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Assay Drug Dev Technol. 2015 Jun;13(5):254-61</RefSource><PMID Version="1">26120951</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Oncol. 2012 Apr;6(2):155-76</RefSource><PMID Version="1">22440008</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Assay Drug Dev Technol. 2015 Jun;13(5):262-5</RefSource><PMID Version="1">26121065</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2016 Jul;15(7):457-71</RefSource><PMID Version="1">26893184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Host Microbe. 2012 May 17;11(5):457-68</RefSource><PMID Version="1">22607799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2012 Feb;33(5):1353-62</RefSource><PMID Version="1">22079002</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Mar 5;519(7541):102-5</RefSource><PMID Version="1">25686603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Aug;32(8):773-85</RefSource><PMID Version="1">25093879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 May 7;161(4):933-45</RefSource><PMID Version="1">25957691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2012 Jun 1;336(6085):1124-8</RefSource><PMID Version="1">22654050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Assay Drug Dev Technol. 2004 Oct;2(5):507-14</RefSource><PMID Version="1">15671648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2011 May 22;8(7):581-6</RefSource><PMID Version="1">21602799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 2004 Sep 13;166(6):877-87</RefSource><PMID Version="1">15364962</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 1990 Dec 1;76(11):2327-36</RefSource><PMID Version="1">2257305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2009 Jan 15;457(7227):277-80</RefSource><PMID Version="1">19098894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Nov 28;346(6213):1258096</RefSource><PMID Version="1">25430774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2000 Sep;68(9):4839-49</RefSource><PMID Version="1">10948095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2003 Jul 20;83(2):173-80</RefSource><PMID Version="1">12768623</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Neurosci. 2013 Sep;56:355-64</RefSource><PMID Version="1">23891805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Genet. 2015 Sep 24;6:300</RefSource><PMID Version="1">26442115</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Comput Biol. 2015 Dec 23;11(12):e1004597</RefSource><PMID Version="1">26699810</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2016 Feb;13(2):151-7</RefSource><PMID Version="1">26689262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Assay Drug Dev Technol. 2013 Mar;11(2):101-7</RefSource><PMID Version="1">23062077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2014 Feb;55(2):378-91</RefSource><PMID Version="1">23566162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2014 Jun 28;106(8):null</RefSource><PMID Version="1">24974129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2011 Mar 24;30(12):1422-35</RefSource><PMID Version="1">21132011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Differentiation. 2012 Sep;84(2):193-202</RefSource><PMID Version="1">22790207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Chip. 2010 Feb 21;10(4):446-55</RefSource><PMID Version="1">20126684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2015 Jun 10;15:466</RefSource><PMID Version="1">26059545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Control Release. 2015 Oct 10;215:39-54</RefSource><PMID Version="1">26220617</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharm. 2014 Jul 7;11(7):2082-91</RefSource><PMID Version="1">24628276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2007 Nov;10(11):1355-60</RefSource><PMID Version="1">17965655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood Cancer J. 2015 Apr 17;5:e307</RefSource><PMID Version="1">25885427</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmaceutics. 2011 Apr 04;3(2):141-70</RefSource><PMID Version="1">24310493</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Enzymol. 2014;546:337-54</RefSource><PMID Version="1">25398348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Hematol. 2001 Dec;74(4):428-36</RefSource><PMID Version="1">11794699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Pharmacol. 2011 Jun;163(4):675-93</RefSource><PMID Version="1">21306581</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Chim Acta. 2016 Jan 15;903:36-50</RefSource><PMID Version="1">26709297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Cardiol. 2016 Jun;13(6):333-49</RefSource><PMID Version="1">27009425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Discov. 2013 Dec;3(12):1416-29</RefSource><PMID Version="1">24056683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2013 Aug 1;73(15):4674-86</RefSource><PMID Version="1">23749641</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2004 Apr;6(4):483-95</RefSource><PMID Version="1">15068789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed J. 2014 May-Jun;37(3):99-105</RefSource><PMID Version="1">24923566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2017 Mar;71(3):319-327</RefSource><PMID Version="1">27160946</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2014 Aug;13(8):577-87</RefSource><PMID Version="1">25033734</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Oct 15;526(7573):361-70</RefSource><PMID Version="1">26469047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol J. 2015 Sep;10 (11):1682-8</RefSource><PMID Version="1">26358782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Feb 27;6:6169</RefSource><PMID Version="1">25721094</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Integr Biol (Camb). 2014 Oct;6(10):988-98</RefSource><PMID Version="1">25183478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2013;18(10):1091-2</RefSource><PMID Version="1">24072218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Jun 16;16:125</RefSource><PMID Version="1">26076868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jun 25;328(5986):1662-8</RefSource><PMID Version="1">20576885</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2011 Mar 31;471(7340):661-5</RefSource><PMID Version="1">21455183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2016 Mar;17(3):170-82</RefSource><PMID Version="1">26818440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2015 Feb 04;16:11</RefSource><PMID Version="1">25648825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 May 10;7:11463</RefSource><PMID Version="1">27163171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Nanotechnol. 2010 Apr;5(4):291-6</RefSource><PMID Version="1">20228788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2015 Dec;148(2):503-16</RefSource><PMID Version="1">26358003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 1992 Sep;202(1):1-8</RefSource><PMID Version="1">1511725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lab Med. 2007 Mar;27(1):139-54</RefSource><PMID Version="1">17416307</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2007 Mar;96(1):2-15</RefSource><PMID Version="1">17122412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Chip. 2010 Apr 7;10(7):857-63</RefSource><PMID Version="1">20300672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Nov 22;342(6161):983-7</RefSource><PMID Version="1">24158904</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2014 Aug;13(8):588-602</RefSource><PMID Version="1">25033736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Bacteriol. 2003 Apr;185(7):2080-95</RefSource><PMID Version="1">12644477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Biotechnol. 2015 Dec;35:118-26</RefSource><PMID Version="1">26094109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2006 Aug 25;126(4):663-76</RefSource><PMID Version="1">16904174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Assay Drug Dev Technol. 2010 Dec;8(6):727-42</RefSource><PMID Version="1">21158687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Liver Dis. 2008 Nov;12(4):759-68, viii</RefSource><PMID Version="1">18984465</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Aug;32(8):760-72</RefSource><PMID Version="1">25093883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol Screen. 2010 Jan;15(1):95-101</RefSource><PMID Version="1">19940084</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343(6166):80-4</RefSource><PMID Version="1">24336569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol Screen. 2013 Jan;18(1):39-53</RefSource><PMID Version="1">22972846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2014 Sep 24;6(255 ):255ra130</RefSource><PMID Version="1">25253673</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Host Microbe. 2013 Feb 13;13(2):129-42</RefSource><PMID Version="1">23414754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Apr 04;7(4):e2154</RefSource><PMID Version="1">23593521</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Chip. 2011 Apr 7;11(7):1256-61</RefSource><PMID Version="1">21347466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20173-8</RefSource><PMID Version="1">19075237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomicrofluidics. 2014 Sep 09;8(5):054106</RefSource><PMID Version="1">25332743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2013 Dec 19;504(7480):389-93</RefSource><PMID Version="1">24284626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2016 Jul 25;6:30420</RefSource><PMID Version="1">27453091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biofabrication. 2015 Mar 02;7(1):015013</RefSource><PMID Version="1">25727374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncogene. 2009 Jan 22;28(3):461-8</RefSource><PMID Version="1">18978815</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):189-99</RefSource><PMID Version="1">16563806</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol Screen. 2013 Jan;18(1):54-66</RefSource><PMID Version="1">22923784</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Feb 10;11(2):e0147215</RefSource><PMID Version="1">26863229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Assay Drug Dev Technol. 2015 Mar;13(2):88-93</RefSource><PMID Version="1">25710279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2003 Nov 17;89(10):1896-900</RefSource><PMID Version="1">14612899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E7-15</RefSource><PMID Version="1">26668389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Sci. 2004 Jul;95(3):311-9</RefSource><PMID Version="1">15272206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Cell Cardiol. 2015 Feb;79:133-44</RefSource><PMID Version="1">25446186</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2011 Nov 27;29(12):1117-9</RefSource><PMID Version="1">22119740</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Oct 07;9(10):e109688</RefSource><PMID Version="1">25289886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Oncol. 2015 Apr 20;5:92</RefSource><PMID Version="1">25941663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Toxicol Sci. 2013 Apr;132(2):317-26</RefSource><PMID Version="1">23315586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEMS Immunol Med Microbiol. 2010 Aug;59(3):269-79</RefSource><PMID Version="1">20618850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2014 Oct 16;514(7522):380-4</RefSource><PMID Version="1">25119044</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Chem Biol. 2009 Jun;13(3):303-8</RefSource><PMID Version="1">19467915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Biotechnol. 2015 Sep;33(9):504-13</RefSource><PMID Version="1">26216543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stem Cell Res. 2013 Mar;10(2):213-27</RefSource><PMID Version="1">23305945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Protoc. 2014 Jan 01;2014(1):106-13</RefSource><PMID Version="1">24371324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2014 Dec 1;20(23):5937-45</RefSource><PMID Version="1">25278454</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2011 Dec 22;2:e246</RefSource><PMID Version="1">22190005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Discov Today. 2016 Sep;21(9):1387-98</RefSource><PMID Version="1">27109386</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dis Model Mech. 2013 Jul;6(4):896-904</RefSource><PMID Version="1">23751357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2011 Dec;21(12):745-54</RefSource><PMID Version="1">22033488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2014 Oct;15(10):647-64</RefSource><PMID Version="1">25237826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Hum Reprod. 2006 Nov;12(11):653</RefSource><PMID Version="1">17008346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell. 2010 Nov 12;143(4):527-39</RefSource><PMID Version="1">21074045</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Res. 2015 Apr;194(2):319-26</RefSource><PMID Version="1">25617973</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2011 Jul 8;9(1):17-23</RefSource><PMID Version="1">21726830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Metastasis. 2009;26(4):381-97</RefSource><PMID Version="1">18958576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 2014 Apr 15;323(1):131-43</RefSource><PMID Version="1">24480576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Exp Cell Res. 2015 Nov 15;339(1):35-43</RefSource><PMID Version="1">26475730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Methods. 2012 Jun 28;9(7):683-9</RefSource><PMID Version="1">22743773</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Mar 28;483(7391):570-5</RefSource><PMID Version="1">22460902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol J. 2006 May;1(5):549-55</RefSource><PMID Version="1">16892290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Transl Med. 2015 Jun 24;7(293):293ps15</RefSource><PMID Version="1">26109101</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Stem Cell. 2013 Dec 5;13(6):691-705</RefSource><PMID Version="1">24315443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biofabrication. 2013 Sep;5(3):035011</RefSource><PMID Version="1">23880658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Placenta. 2005 Apr;26(4):353-7</RefSource><PMID Version="1">15823622</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2015 Mar;14(3):149-50</RefSource><PMID Version="1">25722227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biofabrication. 2013 Mar;5(1):015001</RefSource><PMID Version="1">23172542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Mol Cell Biol. 2007 Oct;8(10):839-45</RefSource><PMID Version="1">17684528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tissue Eng Part A. 2011 Feb;17(3-4):513-21</RefSource><PMID Version="1">20818998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2014 Jan 3;343 (6166):84-7</RefSource><PMID Version="1">24336571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Opt Express. 2015 May 18;23(10):13333-47</RefSource><PMID Version="1">26074583</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2014 Oct;281(19):4450-66</RefSource><PMID Version="1">25131710</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Pharmacol Ther. 2013 Jan;93(1):117-28</RefSource><PMID Version="1">23212109</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2011 May 6;332(6030):687-96</RefSource><PMID Version="1">21551058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2014 Apr;32(4):347-55</RefSource><PMID Version="1">24584096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2014 Feb;35(6):1816-32</RefSource><PMID Version="1">24314552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2015 Dec 21;5:18290</RefSource><PMID Version="1">26687334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2000 Aug 20;69(4):359-69</RefSource><PMID Version="1">10862674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20035-40</RefSource><PMID Version="1">23169653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 2014 Mar;128(6):878-89</RefSource><PMID Version="1">24188029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2006 Nov 15;72(10):1197-206</RefSource><PMID Version="1">16901468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2013 Apr 23;127(16):1677-91</RefSource><PMID Version="1">23519760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2007;2(9):2276-84</RefSource><PMID Version="1">17853884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2006 Sep 29;313(5795):1929-35</RefSource><PMID Version="1">17008526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2008 Aug 29;321(5893):1218-21</RefSource><PMID Version="1">18669821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2010 May 20;465(7296):311-5</RefSource><PMID Version="1">20485428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2009 Jun 12;324(5933):1457-61</RefSource><PMID Version="1">19460966</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2015 Dec 3;528(7580):84-7</RefSource><PMID Version="1">26570998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2013 Jul;123(7):3146-53</RefSource><PMID Version="1">23778137</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14195-200</RefSource><PMID Version="1">19617544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vasc Cell. 2015 Aug 21;7:7</RefSource><PMID Version="1">26301087</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Oct 1;121(7):1463-72</RefSource><PMID Version="1">17546601</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2013 Sep 10;128(11 Suppl 1):S3-13</RefSource><PMID Version="1">24030418</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Microdevices. 2009 Dec;11(6):1145-53</RefSource><PMID Version="1">19554452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Ther Oncol. 2004 Jul;4(2):145-54</RefSource><PMID Version="1">15500009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Chip. 2015 Jun 21;15(12):2688-99</RefSource><PMID Version="1">25996126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Nov 12;306(5699):1194-8</RefSource><PMID Version="1">15539606</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2012 Mar 28;483(7391):603-7</RefSource><PMID Version="1">22460905</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2012 Jun;180(6):2404-16</RefSource><PMID Version="1">22510327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 15;339(6121):819-23</RefSource><PMID Version="1">23287718</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2014 Aug 1;74(15):4016-23</RefSource><PMID Version="1">25015668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1987 Dec;79(6):1367-73</RefSource><PMID Version="1">2891866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Sep 27;367(13):1220-7</RefSource><PMID Version="1">23013073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Res Notes. 2011 Oct 06;4:384</RefSource><PMID Version="1">21978489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Microbiol. 2005 Feb;13(2):58-63</RefSource><PMID Version="1">15680764</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Public Health Genomics. 2015 ;18(6):338-48</RefSource><PMID Version="1">26555355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2010 Mar 31;30(13):4693-706</RefSource><PMID Version="1">20357120</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Appl Microbiol. 1962;4:117-212</RefSource><PMID Version="1">14476232</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3323-8</RefSource><PMID Version="1">20080569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2010 Jul;9(7):702-16</RefSource><PMID Version="1">20610346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Microdevices. 2009 Oct;11(5):1081-9</RefSource><PMID Version="1">19484389</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Biotechnol. 2012 Oct;23(5):803-9</RefSource><PMID Version="1">22326911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol Screen. 2013 Jun;18(5):522-33</RefSource><PMID Version="1">23364514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cardiovasc Transl Res. 2012 Oct;5(5):593-604</RefSource><PMID Version="1">22896035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2012;6(6):e1671</RefSource><PMID Version="1">22720099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2007 May 25;316(5828):1133-4</RefSource><PMID Version="1">17525324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Bioanal Chem. 2010 Sep;398(1):219-26</RefSource><PMID Version="1">20577725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Immunol Immunother. 2013 Apr;62(4):773-85</RefSource><PMID Version="1">23263452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2011 May;10(5):328-9</RefSource><PMID Version="1">21532551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anal Chem. 2006 Jul 1;78(13):4291-8</RefSource><PMID Version="1">16808435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2015 Jul 14;6:7413</RefSource><PMID Version="1">26172574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer Ther. 2010 Jun;9(6):1913-26</RefSource><PMID Version="1">20530715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2006 Apr 10;122(3):372-81</RefSource><PMID Version="1">16446003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2010 Mar;9(3):203-14</RefSource><PMID Version="1">20168317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Comb Chem High Throughput Screen. 2014 Jan;17(1):80-8</RefSource><PMID Version="1">24152227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2013;4:2175</RefSource><PMID Version="1">23868472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Mater Res A. 2010 Jul;94(1):1-8</RefSource><PMID Version="1">20014298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2013 Sep 15;305(6):H913-22</RefSource><PMID Version="1">23832699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2011 Apr;32(8):952-62</RefSource><PMID Version="1">21367833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2008 Apr;47(4):1394-400</RefSource><PMID Version="1">18307210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Drug Discov. 2011 Jun 24;10 (7):507-19</RefSource><PMID Version="1">21701501</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2011 Jul;5(7):e1253</RefSource><PMID Version="1">21811648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biochem. 2010 Aug;341(1-2):73-8</RefSource><PMID Version="1">20333445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vis Exp. 2011 Oct 13;(56):e3089</RefSource><PMID Version="1">22025017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Mol Med. 2011 Jun;15(6):1239-53</RefSource><PMID Version="1">21251211</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(9):e40217</RefSource><PMID Version="1">22957009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Tissue Res. 2013 Apr;352(1):161-77</RefSource><PMID Version="1">23443300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Methods Mol Biol. 2014;1181:61-8</RefSource><PMID Version="1">25070327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Comb Chem High Throughput Screen. 2009 Jan;12(1):24-37</RefSource><PMID Version="1">19149489</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cancer. 2015 Jul 31;14:147</RefSource><PMID Version="1">26227951</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018929" MajorTopicYN="N">Cell Culture Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002461" MajorTopicYN="N">Cell Line, Transformed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="N">Pharmaceutical Preparations</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27616293</ArticleId><ArticleId IdType="pii">nrd.2016.175</ArticleId><ArticleId IdType="doi">10.1038/nrd.2016.175</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Espagne</li><li>Finlande</li><li>France</li><li>Pays-Bas</li><li>Royaume-Uni</li><li>Suisse</li></country><region><li>Angleterre</li><li>Canton de Vaud</li><li>Communauté de Madrid</li><li>District de Dresde</li><li>Hollande-Méridionale</li><li>Oxfordshire</li><li>Saxe (Land)</li><li>Uusimaa</li><li>Écosse</li><li>Île-de-France</li></region><settlement><li>Dresde</li><li>Helsinki</li><li>Lausanne</li><li>Leyde</li><li>Madrid</li><li>Oxford</li><li>Paris</li><li>Édimbourg</li></settlement><orgName><li>Université d'Helsinki</li><li>Université d'Oxford</li><li>Université d'Édimbourg</li></orgName></list><tree><noCountry><name sortKey="Davies, Anthony M" sort="Davies, Anthony M" uniqKey="Davies A" first="Anthony M" last="Davies">Anthony M. Davies</name></noCountry><country name="Finlande"><region name="Uusimaa"><name sortKey="Horvath, Peter" sort="Horvath, Peter" uniqKey="Horvath P" first="Peter" last="Horvath">Peter Horvath</name></region><name sortKey="Ostling, P Ivi" sort="Ostling, P Ivi" uniqKey="Ostling P" first="P Ivi" last="Östling">P Ivi Östling</name><name sortKey="Pieti Inen, Vilja" sort="Pieti Inen, Vilja" uniqKey="Pieti Inen V" first="Vilja" last="Pieti Inen">Vilja Pieti Inen</name><name sortKey="Von Schantz, Carina" sort="Von Schantz, Carina" uniqKey="Von Schantz C" first="Carina" last="Von Schantz">Carina Von Schantz</name></country><country name="France"><region name="Île-de-France"><name sortKey="Aulner, Nathalie" sort="Aulner, Nathalie" uniqKey="Aulner N" first="Nathalie" last="Aulner">Nathalie Aulner</name></region><name sortKey="Nery, Elaine Del" sort="Nery, Elaine Del" uniqKey="Nery E" first="Elaine Del" last="Nery">Elaine Del Nery</name><name sortKey="Shorte, Spencer L" sort="Shorte, Spencer L" uniqKey="Shorte S" first="Spencer L" last="Shorte">Spencer L. Shorte</name></country><country name="Allemagne"><region name="Saxe (Land)"><name sortKey="Bickle, Marc" sort="Bickle, Marc" uniqKey="Bickle M" first="Marc" last="Bickle">Marc Bickle</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Ebner, Daniel" sort="Ebner, Daniel" uniqKey="Ebner D" first="Daniel" last="Ebner">Daniel Ebner</name></region><name sortKey="Carragher, Neil O" sort="Carragher, Neil O" uniqKey="Carragher N" first="Neil O" last="Carragher">Neil O. Carragher</name></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Montoya, Maria C" sort="Montoya, Maria C" uniqKey="Montoya M" first="Maria C" last="Montoya">Maria C. Montoya</name></region></country><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Price, Leo S" sort="Price, Leo S" uniqKey="Price L" first="Leo S" last="Price">Leo S. Price</name></region></country><country name="Suisse"><region name="Canton de Vaud"><name sortKey="Turcatti, Gerardo" sort="Turcatti, Gerardo" uniqKey="Turcatti G" first="Gerardo" last="Turcatti">Gerardo Turcatti</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003B24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:27616293
|texte= Screening out irrelevant cell-based models of disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:27616293" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |